We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,620.00
Bid: 1,619.00
Ask: 1,621.00
Change: 11.00 (0.68%)
Spread: 2.00 (0.124%)
Open: 1,620.00
High: 1,623.00
Low: 1,614.00
Prev. Close: 1,609.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Smiths Group to divest Artificial Lift business

23 Sep 2016 07:00

RNS Number : 6464K
Smiths Group PLC
23 September 2016
 

 

News Release

London, 23 September 2016

For immediate release

 

 

Smiths Group divestment of its Artificial Lift business

Smiths Group plc ("Smiths Group" or the "Group") today announces that it has entered into an agreement to sell its Artificial Lift business ("Artificial Lift"), part of the John Crane division, to Endurance Lift Solutions, LLC. The total gross consideration payable at completion is $39.5m in cash subject to an adjustment based upon the working capital position at completion.

Artificial Lift is engaged in the sale of products and services, principally sucker rods for onshore upstream oil and gas customers in the United States and Romania.

For the year ended 31 July 2015, the business and assets subject to the transaction had combined revenues of $90.8m and an operating loss before certain non-recurring items of $1.8m. The gross assets of the combined business at 31 July 2015 were $63.2m.

For the unaudited year ended 31 July 2016, the business and assets subject to the transaction had combined revenues of $53.4m and an operating loss before certain non-recurring items of $10.1m. The gross assets of the combined business at 31 July 2016 were $32.1m.

The management team will transfer with the business. The transaction is subject to customary regulatory approvals and is expected to close by the end of the calendar year.

Andy Reynolds Smith, Chief Executive of Smiths Group, commented as follows: "This disposal demonstrates our ongoing commitment to increasingly focus our portfolio on building technology differentiated leadership positions in our chosen markets. The capital released from this transaction will be reinvested in attractive growth opportunities, whilst allowing the Artificial Lift business to progress under different ownership."

PPHB, an independent investment banking firm focused on the energy services sector, acted as exclusive financial advisor to Smiths Group in the sale of Artificial Lift.

ENDS

 

 

Contact details

 

Investor enquiries

Andrew Lappin, Smiths Group

+44 (0)20 7004 1657

+44 (0)78 0500 7035

andrew.lappin@smiths.com

 

Kirsty Law, Smiths Group

+44 (0)20 7004 1672

+44 (0)75 8315 4386

kirsty.law@smiths.com

 

Media enquiries

Andrew Lorenz, FTI Consulting

+44 (0)203 727 1323

+44 (0)777 564 1807

smiths@fticonsulting.com

 

 

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs more than 23,000 people in over 50 countries. For more information visit www.smiths.com

 

 

Disclaimer

This announcement contains certain statements that are forward-looking statements. They appear in a number of places throughout this announcement and include statements regarding our intentions, beliefs or current expectations and those of our officers, directors and employees concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the business we operate. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and, unless otherwise required by applicable law, Smiths undertakes no obligation to update or revise these forward-looking statements. Nothing in this document should be construed as a profit forecast.

 

No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per Smiths ordinary share for the current or future financial years would necessarily match or exceed the historical published earnings per Smiths ordinary share. Prices and values of, and income from, shares may go down as well as up and an investor may not get back the amount invested. It should be noted that past performance is no guide to future performance. Persons needing advice should consult an independent financial adviser. Any statement to the effect that the Acquisition is expected to be earnings enhancing for Smiths should not be interpreted to mean that earnings per Smiths ordinary share in the first full financial year following the Acquisition, nor in any subsequent period, will necessarily match or be greater than those for a preceding financial year.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEWSIDFMSELU
Date   Source Headline
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:15 amRNSShare buyback programme
26th Mar 20247:01 amRNSSmiths Group half year results
26th Mar 20247:00 amRNSDirectorate Change
1st Mar 20247:00 amRNSSmiths sells 830,000 shares in ICU Medical Inc
29th Feb 20249:00 amRNSDirectors' Change in Responsibilities
1st Feb 202410:15 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirectors' Change in Responsibilities
30th Nov 20237:00 amRNSSmiths Group plc - John Crane deep dive
16th Nov 20231:10 pmRNSResult of AGM
16th Nov 20237:00 amRNSSmiths Group plc - Q1 Trading Update
2nd Nov 20232:45 pmRNSDirector/PDMR Shareholding
1st Nov 202310:00 amRNSBlock listing Interim Review
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:25 pmRNSDirector/PDMR Shareholding
12th Oct 202312:35 pmRNSAnnual Financial Report and AGM 2023
4th Oct 202310:00 amRNSDirector/PDMR Shareholding
2nd Oct 202312:10 pmRNSTotal Voting Rights
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSSmiths Group FY23 Full Year Results
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares
14th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20237:00 amRNSTransaction in Own Shares
12th Sep 20237:00 amRNSTransaction in Own Shares
11th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.